Fatal early-onset checkpoint inhibitor pneumonitis in a patient with advanced squamous-cell lung cancer with underlying pulmonary fibrosis: a case report and review of the literature
This case illustrates that life-threatening CIP can occur after a single dose of ICI in patients with fibrotic ILD. It emphasizes the urgent need for risk-adapted treatment strategies and enhanced monitoring protocols in this high-risk population.
Authors
- Anna Rybacka
- Daria M. Keller (ORCID: https://orcid.org/0000-0002-8570-1812)
- Barbara Kuźnar-Kamińska (ORCID: https://orcid.org/0000-0001-7236-5023)
- Dagobert Żarczyński
Institutions
- Poznan University of Medical Sciences (PL)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-11-04
- DOI
- https://doi.org/10.3389/fonc.2025.1672093
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00